Neurological and neurobehavioral assessment of experimental subarachnoid hemorrhage

BMC Neuroscience

Volumn 10, Issue , 2009, Pages 103-

  Jeon, Hyojin ^a   Ai, Jinglu ^a   Sabri, Mohamed ^a   Tariq, Asma ^a   Shang, Xueyuan ^a   Chen, Gang ^a   Macdonald, R Loch ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AVOIDANCE BEHAVIOR; BODY EQUILIBRIUM; BRAIN ISCHEMIA; BRAIN VASOSPASM; COGNITION; DISEASE MODEL; EXPLORATORY BEHAVIOR; INTRACRANIAL HYPERTENSION; LEARNING; MAZE TEST; MENTAL PERFORMANCE; MORTALITY; NEUROPSYCHOLOGICAL TEST; NONHUMAN; ROTAROD TEST; SHORT TERM MEMORY; SPATIAL MEMORY; SUBARACHNOID HEMORRHAGE; WEIGHT CHANGE; WORKING MEMORY; ANIMAL; ANIMAL BEHAVIOR; BIOASSAY; BRAIN; MOTOR PERFORMANCE; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; RAT; REVIEW;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DISEASE MODELS, ANIMAL; ENDPOINT DETERMINATION; MICE; MOTOR SKILLS; NEUROPSYCHOLOGICAL TESTS; RATS; SUBARACHNOID HEMORRHAGE;

EID: 70349781118     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-10-103     Document Type: Article

References (112)

1. Germano A, Caffo M, Angileri FF, Arcadi F, Newcomb-Fernandez J, Caruso G, Meli F, Pineda JA, Lewis SB, Wang KK. NMDA receptor antagonist felbamate reduces behavioral deficits and blood-brain barrier permeability changes after experimental subarachnoid hemorrhage in the rat. J Neurotrauma 2007, 24:732-744. 10.1089/neu.2006.0181, 17439355.
2. Andaluz N, Zuccarello M. Recent trends in the treatment of cerebral aneurysms: analysis of a nationwide inpatient database. J Neurosurg 2008, 108:1163-1169. 10.3171/JNS/2008/108/6/1163, 18518722.
3. van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: diagnosis, causes and management. Brain 2001, 124:249-278. 10.1093/brain/124.2.249, 11157554.
4. Macdonald RL, Pluta RM, Zhang JH. Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat Clin Pract Neurol 2007, 3:256-263. 10.1038/ncpneuro0490, 17479073.
5. Hansen-Schwartz J, Vajkoczy P, Macdonald RL, Pluta RM, Zhang JH. Cerebral vasospasm: looking beyond vasoconstriction. Trends Pharmacol Sci 2007, 28:252-256. 10.1016/j.tips.2007.04.002, 17466386.
6. Dreier JP, Sakowitz OW, Harder A, Zimmer C, Dirnagl U, Valdueza JM, Unterberg AW. Focal laminar cortical MR signal abnormalities after subarachnoid hemorrhage. Annals of Neurology 2002, 52:825-829. 10.1002/ana.10383, 12447937.
7. Nolan CP, Macdonald RL. Can angiographic vasospasm be used as a surrogate marker in evaluating therapeutic interventions for cerebral vasospasm?. Neurosurg Focus 2006, 21:E1. 10.3171/foc.2006.21.3.1, 17029333.
8. Corbett D, Nurse S. The problem of assessing effective neuroprotection in experimental cerebral ischemia. Prog Neurobiol 1998, 54:531-548. 10.1016/S0301-0082(97)00078-6, 9550190.
9. Warner MA, Nadler JV, Crain BJ. Effects of NMDA receptor antagonists and body temperature in the gerbil carotid occlusion model of transient forebrain ischemia. Current and Future Trends in Anticonvulsant, Anxiety and Stroke Therapy 1990, 409-414. New York: Wiley-Liss, Inc, Meldrum BS, Williams M.
10. Megyesi JF, Vollrath B, Cook DA, Findlay JM. In vivo animal models of cerebral vasospasm: a review. Neurosurgery 2000, 46:448-460. 10.1097/00006123-200002000-00035, 10690735.
11. Prunell GF, Mathiesen T, Svendgaard NA. A new experimental model in rats for study of the pathophysiology of subarachnoid hemorrhage. Neuroreport 2002, 13:2553-2556. 10.1097/00001756-200212200-00034, 12499866.
12. d'Avella D, Germano A, Santoro G, Costa G, Zuccarello M, Caputi AP, Hayes RL, Tomasello F. Effect of experimental subarachnoid hemorrhage on CSF eicosanoids in the rat. J Neurotrauma 1990, 7:121-129. 10.1089/neu.1990.7.121, 2258943.
13. Germano AF, Dixon CE, d'Avella D, Hayes RL, Tomasello F. Behavioral deficits following experimental subarachnoid hemorrhage in the rat. J Neurotrauma 1994, 11:345-353. 10.1089/neu.1994.11.345, 7996588.
14. Imperatore C, Germano A, d'Avella D, Tomasello F, Costa G. Effects of the radical scavenger AVS on behavioral and BBB changes after experimental subarachnoid hemorrhage. Life Sci 2000, 66:779-790. 10.1016/S0024-3205(99)00651-7, 10698353.
15. Gules I, Satoh M, Clower BR, Nanda A, Zhang JH. Comparison of three rat models of cerebral vasospasm. Am J Physiol Heart Circ Physiol 2002, 283:H2551-H2559.
16. Prunell GF, Mathiesen T, Diemer NH, Svendgaard NA. Experimental subarachnoid hemorrhage: subarachnoid blood volume, mortality rate, neuronal death, cerebral blood flow, and perfusion pressure in three different rat models. Neurosurgery 2003, 52:165-175. 10.1097/00006123-200301000-00022, 12493115.
17. Bederson JB, Germano IM, Guarino L. Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke 1995, 26:1086-1091.
18. Park S, Yamaguchi M, Zhou C, Calvert JW, Tang J, Zhang JH. Neurovascular protection reduces early brain injury after subarachnoid hemorrhage. Stroke 2004, 35:2412-2417. 10.1161/01.STR.0000141162.29864.e9, 15322302.
19. Zausinger S, Thal SC, Kreimeier U, Messmer K, Schmid-Elsaesser R. Hypertonic fluid resuscitation from subarachnoid hemorrhage in rats. Neurosurgery 2004, 55:679-686. 10.1227/01.NEU.0000134558.28977.EE, 15335436.
20. Cahill J, Calvert JW, Solaroglu I, Zhang JH. Vasospasm and p53-induced apoptosis in an experimental model of subarachnoid hemorrhage. Stroke 2006, 37:1868-1874. 10.1161/01.STR.0000226995.27230.96, 16741174.
21. Scholler K, Trinkl A, Klopotowski M, Thal SC, Plesnila N, Trabold R, Hamann GF, Schmid-Elsaesser R, Zausinger S. Characterization of microvascular basal lamina damage and blood-brain barrier dysfunction following subarachnoid hemorrhage in rats. Brain Res 2007, 1142:237-246. 10.1016/j.brainres.2007.01.034, 17303089.
22. Sugawara T, Ayer R, Jadhav V, Zhang JH. A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model. J Neurosci Methods 2008, 167:327-334. 2259391, 17870179, 10.1016/j.jneumeth.2007.08.004.
23. Gao C, Liu X, Liu W, Shi H, Zhao Z, Chen H, Zhao S. Anti-apoptotic and neuroprotective effects of tetramethylpyrazine following subarachnoid hemorrhage in rats. Auton Neurosci 2008, 141:22-30. 10.1016/j.autneu.2008.04.007, 18558517.
24. Germano A, Imperatore C, d'Avella D, Costa G, Tomasello F. Antivasospastic and brain-protective effects of a hydroxyl radical scavenger (AVS) after experimental subarachnoid hemorrhage. J Neurosurg 1998, 88:1075-1081. 10.3171/jns.1998.88.6.1075, 9609303.
25. Germano A, Costa C, DeFord SM, Angileri FF, Arcadi F, Pike BR, Bramanti P, Bausano B, Zhao X, Day AL. Systemic administration of a calpain inhibitor reduces behavioral deficits and blood-brain barrier permeability changes after experimental subarachnoid hemorrhage in the rat. J Neurotrauma 2002, 19:887-896. 10.1089/08977150260190474, 12184858.
26. Katz L, Ebmeyer U, Safar P, Radovsky A, Neumar R. Outcome model of asphyxial cardiac arrest in rats. J Cereb Blood Flow Metab 1995, 15:1032-1039.
27. Vaagenes P, Safar P, Diven W, Moossy J, Rao G, Cantadore R, Kelsey S. Brain enzyme levels in CSF after cardiac arrest and resuscitation in dogs: markers of damage and predictors of outcome. J Cereb Blood Flow Metab 1988, 8:262-275.
28. Bermueller C, Thal SC, Plesnila N, Schmid-Elsaesser R, Kreimeier U, Zausinger S. Hypertonic fluid resuscitation from subarachnoid hemorrhage in rats: a comparison between small volume resuscitation and mannitol. J Neurol Sci 2006, 241:73-82. 10.1016/j.jns.2005.10.016, 16343544.
29. Thal SC, Mebmer K, Schmid-Elsaesser R, Zausinger S. Neurological impairment in rats after subarachnoid hemorrhage - a comparison of functional tests. J Neurol Sci 2008, 268:150-159. 10.1016/j.jns.2007.12.002, 18191151.
30. Garcia JH, Wagner S, Liu KF, Hu XJ. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 1995, 26:627-634.
31. Cahill J, Calvert JW, Marcantonio S, Zhang JH. p53 may play an orchestrating role in apoptotic cell death after experimental subarachnoid hemorrhage. Neurosurgery 2007, 60:531-545. 10.1227/01.NEU.0000249287.99878.9B, 17327799.
32. Ostrowski RP, Colohan AR, Zhang JH. Mechanisms of hyperbaric oxygen-induced neuroprotection in a rat model of subarachnoid hemorrhage. J Cereb Blood Flow Metab 2005, 25:554-571. 10.1038/sj.jcbfm.9600048, 15703702.
33. Sugawara T, Ayer R, Jadhav V, Chen W, Tsubokawa T, Zhang JH. Simvastatin attenuation of cerebral vasospasm after subarachnoid hemorrhage in rats via increased phosphorylation of Akt and endothelial nitric oxide synthase. J Neurosci Res 2008, 86:3635-3643. 2691855, 18683242, 10.1002/jnr.21807.
34. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986, 17:472-476.
35. Zausinger S, Hungerhuber E, Baethmann A, Reulen H, Schmid-Elsaesser R. Neurological impairment in rats after transient middle cerebral artery occlusion: a comparative study under various treatment paradigms. Brain Res 2000, 863:94-105. 10.1016/S0006-8993(00)02100-4, 10773197.
36. Feldman Z, Gurevitch B, Artru AA, Oppenheim A, Shohami E, Reichenthal E, Shapira Y. Effect of magnesium given 1 hour after head trauma on brain edema and neurological outcome. J Neurosurg 1996, 85:131-137. 10.3171/jns.1996.85.1.0131, 8683262.
37. Yatsushige H, Ostrowski RP, Tsubokawa T, Colohan A, Zhang JH. Role of c-Jun N-terminal kinase in early brain injury after subarachnoid hemorrhage. J Neurosci Res 2007, 85:1436-1448. 10.1002/jnr.21281, 17410600.
38. Silasi G, Colbourne F. Long-term assessment of motor and cognitive behaviours in the intraluminal perforation model of subarachnoid hemorrhage in rats. Behav Brain Res 2009, 198:380-387. 10.1016/j.bbr.2008.11.019, 19059287.
39. Takata K, Sheng H, Borel CO, Laskowitz DT, Warner DS, Lombard FW. Long-term cognitive dysfunction following experimental subarachnoid hemorrhage: new perspectives. Exp Neurol 2008, 213:336-344. 10.1016/j.expneurol.2008.06.009, 18625221.
40. Germano A, Caruso G, Caffo M, Cacciola F, Belvedere M, Tisano A, Raffaele M, Tomasello F. Does subarachnoid blood extravasation per se induce long-term neuropsychological and cognitive alterations?. Acta Neurochir 1998, 140:805-811.
41. D'Hooge R, De Deyn PP. Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 2001, 36:60-90. 10.1016/S0165-0173(01)00067-4, 11516773.
42. Elsersy H, Sheng H, Lynch JR, Moldovan M, Pearlstein RD, Warner DS. Effects of isoflurane versus fentanyl-nitrous oxide anesthesia on long-term outcome from severe forebrain ischemia in the rat. Anesthesiology 2004, 100:1160-1166. 10.1097/00000542-200405000-00018, 15114213.
43. Asano T, Takakura K, Sano K, Kikuchi H, Nagai H, Saito I, Tamura A, Ochiai C, Sasaki T. Effects of a hydroxyl radical scavenger on delayed ischemic neurological deficits following aneurysmal subarachnoid hemorrhage: results of a multicenter, placebo-controlled double-blind trial. J Neurosurg 1996, 84:792-803. 10.3171/jns.1996.84.5.0792, 8622153.
44. Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled?. Ann Intern Med 1996, 125:605-613.
45. Kreiter KT, Copeland D, Bernardini GL, Bates JE, Peery S, Claassen J, Du YE, Stern Y, Connolly ES, Mayer SA. Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke 2002, 33:200-208. 10.1161/hs0102.101080, 11779911.
46. Anderson SW, Todd MM, Hindman BJ, Clarke WR, Torner JC, Tranel D, Yoo B, Weeks J, Manzel KW, Samra S. Effects of intraoperative hypothermia on neuropsychological outcomes after intracranial aneurysm surgery. Ann Neurol 2006, 60:518-527. 10.1002/ana.21018, 17120252.
47. Germano A, d'Avella D, Imperatore C, Caruso G, Tomasello F. Time-course of blood-brain barrier permeability changes after experimental subarachnoid haemorrhage. Acta Neurochir (Wien) 2000, 142:575-580. 10.1007/s007010050472, 10898366.
48. Prunell GF, Mathiesen T, Svendgaard NA. Experimental subarachnoid hemorrhage: cerebral blood flow and brain metabolism during the acute phase in three different models in the rat. Neurosurgery 2004, 54:426-436. 10.1227/01.NEU.0000103670.09687.7A, 14744290.
49. Prunell GF, Svendgaard NA, Alkass K, Mathiesen T. Delayed cell death related to acute cerebral blood flow changes following subarachnoid hemorrhage in the rat brain. J Neurosurg 2005, 102:1046-1054. 10.3171/jns.2005.102.6.1046, 16028764.
50. Gao L, Hoi Y, Swartz DD, Kolega J, Siddiqui A, Meng H. Nascent aneurysm formation at the basilar terminus induced by hemodynamics. Stroke 2008, 39:2085-2090. 2559803, 18451348, 10.1161/STROKEAHA.107.509422.
51. Gerlai R. Behavioral tests of hippocampal function: simple paradigms complex problems. Behav Brain Res 2001, 125:269-277. 10.1016/S0166-4328(01)00296-0, 11682118.
52. Araujo JA, Chan AD, Winka LL, Seymour PA, Milgram NW. Dose-specific effects of scopolamine on canine cognition: impairment of visuospatial memory, but not visuospatial discrimination. Psychopharmacology (Berl) 2004, 175:92-98. 10.1007/s00213-004-1777-y, 15029470.
53. Buccafusco JJ. Methods of Behavior Analysis in Neuroscience 2009, Boca Raton: CRC/Taylor & Francis.
54. Ravnik J, Starovasnik B, Sesok S, Pirtosek Z, Svigelj V, Bunc G, Bosnjak R. Long-term cognitive deficits in patients with good outcomes after aneurysmal subarachnoid hemorrhage from anterior communicating artery. Croat Med J 2006, 47:253-263. 2080389, 16625690.
55. Bendel P, Koivisto T, Kononen M, Hanninen T, Hurskainen H, Saari T, Vapalahti M, Hernesniemi J, Vanninen R. MR imaging of the brain 1 year after aneurysmal subarachnoid hemorrhage: randomized study comparing surgical with endovascular treatment. Radiology 2008, 246:543-552. 10.1148/radiol.2461061915, 18056855.
56. Santiago-Ramajo S, Katati MJ, Perez-Garcia M, Coin-Mejias MA, Vilar-Lopez R, Caracuel-Romero A, rjona-Moron V. Neuropsychological evaluation of the treatments applied to intracranial aneurysms in a Spanish sample. J Clin Exp Neuropsychol 2007, 29:634-641. 10.1080/13803390600879024, 17691036.
57. Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 2006, 1:848-858. 10.1038/nprot.2006.116, 17406317.
58. Winocur G, Hasher L. Age and time-of-day effects on learning and memory in a non-matching-to-sample test. Neurobiol Aging 2004, 25:1107-1115. 10.1016/j.neurobiolaging.2003.10.005, 15212835.
59. Birrell JM, Brown VJ. Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci 2000, 20:4320-4324.
60. Bissonette GB, Martins GJ, Franz TM, Harper ES, Schoenbaum G, Powell EM. Double dissociation of the effects of medial and orbital prefrontal cortical lesions on attentional and affective shifts in mice. J Neurosci 2008, 28:11124-11130. 2657142, 18971455, 10.1523/JNEUROSCI.2820-08.2008.
61. Fukatsu R, Yamadori A, Fujii T. Impaired recall and preserved encoding in prominent amnesic syndrome: a case of basal forebrain amnesia. Neurology 1998, 50:539-541.
62. Fujii T, Suzuki M, Suzuki K, Ohtake H, Tsukiura T, Miura R. Normal memory and no confabulation after extensive damage to the orbitofrontal cortex. J Neurol Neurosurg Psychiatry 2005, 76:1309-1310. 1739779, 16107380, 10.1136/jnnp.2004.061846.
63. Parra A, McGirt MJ, Sheng H, Laskowitz DT, Pearlstein RD, Warner DS. Mouse model of subarachnoid hemorrhage associated cerebral vasospasm: methodological analysis. Neurol Res 2002, 24:510-516. 10.1179/016164102101200276, 12117325.
64. Kamii H, Kato I, Kinouchi H, Chan PH, Epstein CJ, Akabane A, Okamoto H, Yoshimoto T. Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice overexpressing CuZn-superoxide dismutase. Stroke 1999, 30:867-871.
65. Lin CL, Calisaneller T, Ukita N, Dumont AS, Kassell NF, Lee KS. A murine model of subarachnoid hemorrhage-induced cerebral vasospasm. J Neurosci Methods 2003, 123:89-97. 10.1016/S0165-0270(02)00344-8, 12581852.
66. Crawley J. What's Wrong with my Mouse: Behavioral Phenotyping of Transgenic and Knockout Mice 2000, New York: John Wiley & Sons.
67. McGirt MJ, Lynch JR, Parra A, Sheng H, Pearlstein RD, Laskowitz DT, Pelligrino DA, Warner DS. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 2002, 33:2950-2956. 10.1161/01.STR.0000038986.68044.39, 12468796.
68. McGirt MJ, Parra A, Sheng H, Higuchi Y, Oury TD, Laskowitz DT, Pearlstein RD, Warner DS. Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing extracellular superoxide dismutase. Stroke 2002, 33:2317-2323. 10.1161/01.STR.0000027207.67639.1E, 12215605.
69. Mesis RG, Wang H, Lombard FW, Yates R, Vitek MP, Borel CO, Warner DS, Laskowitz DT. Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage. Neurosurg Focus 2006, 21:E4. 10.3171/foc.2006.21.3.4, 17029343.
70. Clark WM, Lessov NS, Dixon MP, Eckenstein F. Monofilament intraluminal middle cerebral artery occlusion in the mouse. Neurol Res 1997, 19:641-648.
71. Petullo D, Masonic K, Lincoln C, Wibberley L, Teliska M, Yao DL. Model development and behavioral assessment of focal cerebral ischemia in rats. Life Sci 1999, 64:1099-1108. 10.1016/S0024-3205(99)00038-7, 10210272.
72. Reglodi D, Tamas A, Lengvari I. Examination of sensorimotor performance following middle cerebral artery occlusion in rats. Brain Res Bull 2003, 59:459-466. 10.1016/S0361-9230(02)00962-0, 12576143.
73. Yokoo N, Sheng H, Mixco J, Homi HM, Pearlstein RD, Warner DS. Intraischemic nitrous oxide alters neither neurologic nor histologic outcome: a comparison with dizocilpine. Anesth Analg 2004, 99:896-903. 10.1213/01.ANE.0000132973.32387.8B, 15333428.
74. Gao J, Wang H, Sheng H, Lynch JR, Warner DS, Durham L, Vitek MP, Laskowitz DT. A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage. Neurocrit Care 2006, 4:25-31. 10.1385/NCC:4:1:025, 16498192.
75. Vergouwen MD, Vermeulen M, de Haan RJ, Levi M, Roos YB. Dihydropyridine calcium antagonists increase fibrinolytic activity: a systematic review. J Cereb Blood Flow Metab 2007, 27:1293-1308. 10.1038/sj.jcbfm.9600431, 17191079.
76. Wang H, Gao J, Lassiter TF, McDonagh DL, Sheng H, Warner DS, Lynch JR, Laskowitz DT. Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage. Neurocrit Care 2006, 5:71-78. 10.1385/NCC:5:1:71, 16960300.
77. Buemi M, Grasso G, Corica F, Calapai G, Salpietro FM, Casuscelli T, Sfacteria A, Aloisi C, Alafaci C, Sturiale A. In vivo evidence that erythropoietin has a neuroprotective effect during subarachnoid hemorrhage. Eur J Pharmacol 2000, 392:31-34. 10.1016/S0014-2999(00)00081-9, 10748269.
78. Zhou ML, Shi JX, Zhu JQ, Hang CH, Mao L, Chen KF, Yin HX. Comparison between one- and two-hemorrhage models of cerebral vasospasm in rabbits. J Neurosci Methods 2007, 159:318-324. 10.1016/j.jneumeth.2006.07.026, 16942802.
79. Endo S, Branson PJ, Alksne JF. Experimental model of symptomatic vasospasm in rabbits. Stroke 1988, 19:1420-1425.
80. Nomura H, Hirashima Y, Endo S, Takaku A. Anticardiolipin antibody aggravates cerebral vasospasm after subarachnoid hemorrhage in rabbits. Stroke 1998, 29:1014-1018.
81. Tang WH, Chen Z, Liu Z, Zhang JH, Xi G, Feng H. The effect of ecdysterone on cerebral vasospasm following experimental subarachnoid hemorrhage in vitro and in vivo. Neurol Res 2008, 30:571-580. 2706528, 18647496, 10.1179/174313208X297986.
82. Otsuji T, Endo S, Hirashima Y, Nishijima M, Takaku A. An experimental model of symptomatic vasospasm induced by oxyhemoglobin in rabbits. Stroke 1994, 25:657-662.
83. Laslo AM, Eastwood JD, Pakkiri P, Chen F, Lee TY. CT Perfusion-Derived Mean Transit Time Predicts Early Mortality and Delayed Vasospasm after Experimental Subarachnoid Hemorrhage. AJNR Am J Neuroradiol 2008, 29:79-85. 10.3174/ajnr.A0747, 17965139.
84. Woodruff-Pak DS, Green JT, Pak JT, Heifets B, Pak MH. The effect of scopolamine in older rabbits tested in the 750 ms delay eyeblink classical conditioning procedure. Integr Physiol Behav Sci 2002, 37:103-113. 10.1007/BF02688823, 12186305.
85. Freeman JH, Weible A, Rossi J, Gabriel M. Lesions of the entorhinal cortex disrupt behavioral and neuronal responses to context change during extinction of discriminative avoidance behavior. Exp Brain Res 1997, 115:445-457. 10.1007/PL00005714, 9262199.
86. Pavlova IV, Levshina IP, Vanetsian GL, Shuikin NN, Zyablitseva EA. Behavior and measures of respiration in rabbits differing in terms of movement activity in an open field. Neurosci Behav Physiol 2007, 37:33-41. 10.1007/s11055-007-0146-9, 17180316.
87. Hayakawa T, Waltz AG. Experimental subarachnoid hemorrhage from a middle cerebral artery. Neurologic deficits, intracranial pressures, blood pressures, and pulse rates. Stroke 1977, 8:421-426.
88. Diringer MN, Heffez DS, Monsein L, Kirsch JR, Hanley DF, Traystman RJ. Cerebrovascular CO2 reactivity during delayed vasospasm in a canine model of subarachnoid hemorrhage. Stroke 1991, 22:367-372.
89. White RP, Hagen AA, Robertson JT. Effect of nonsteroid anti-inflammatory drugs on subarachnoid hemorrhage in dogs. J Neurosurg 1979, 51:164-171. 10.3171/jns.1979.51.2.0164, 582181.
90. White RP, Huang SP, Hagen AA, Robertson JT. Experimental assessment of phenoxybenzamine in cerebral vasospasm. J Neurosurg 1979, 50:158-163. 10.3171/jns.1979.50.2.0158, 430126.
91. Alexander E, Black PM, Liszczak TM, Zervas NT. Delayed CSF lavage for arteriographic and morphological vasospasm after experimental SAH. J Neurosurg 1985, 63:949-958. 10.3171/jns.1985.63.6.0949, 4056908.
92. Kaoutzanis M, Yokota M, Sibilia R, Peterson JW. Neurologic evaluation in a canine model of single and double subarachnoid hemorrhage. J Neurosci Methods 1993, 50:301-307. 10.1016/0165-0270(93)90037-R, 8152241.
93. Tibbs R, Zubkov A, Aoki K, Meguro T, Badr A, Parent A, Zhang J. Effects of mitogen-activated protein kinase inhibitors on cerebral vasospasm in a double-hemorrhage model in dogs. J Neurosurg 2000, 93:1041-1047. 10.3171/jns.2000.93.6.1041, 11117847.
94. Aoki K, Zubkov AY, Ross IB, Zhang JH. Therapeutic effect of caspase inhibitors in the prevention of apoptosis and reversal of chronic cerebral vasospasm. J Clin Neurosci 2002, 9:672-677. 10.1054/jocn.2002.1088, 12604282.
95. Aoki K, Zubkov AY, Tibbs RE, Zhang JH. Role of MAPK in chronic cerebral vasospasm. Life Sci 2002, 70:1901-1908. 10.1016/S0024-3205(02)01499-6, 12005175.
96. Perkins E, Kimura H, Parent AD, Zhang JH. Evaluation of the microvasculature and cerebral ischemia after experimental subarachnoid hemorrhage in dogs. J Neurosurg 2002, 97:896-904. 10.3171/jns.2002.97.4.0896, 12405379.
97. Kimura H, Meguro T, Badr A, Zhang JH. Suramin-induced reversal of chronic cerebral vasospasm in experimental subarachnoid hemorrhage. J Neurosurg 2002, 97:129-135. 10.3171/jns.2002.97.1.0129, 12134903.
98. Kimura H, Sasaki K, Meguro T, Zhang JH. Phosphatidylinositol 3-kinase inhibitor failed to reduce cerebral vasospasm in dog model of experimental subarachnoid hemorrhage. Stroke 2002, 33:593-599. 10.1161/hs0202.103398, 11823675.
99. Zhou C, Yamaguchi M, Kusaka G, Schonholz C, Nanda A, Zhang JH. Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab 2004, 24:419-431. 10.1097/00004647-200404000-00007, 15087711.
100. Yamaguchi M, Zhou C, Nanda A, Zhang JH. Ras protein contributes to cerebral vasospasm in a canine double-hemorrhage model. Stroke 2004, 35:1750-1755. 10.1161/01.STR.0000129898.68350.9f, 15143294.
101. Yatsushige H, Yamaguchi M, Zhou C, Calvert JW, Zhang JH. Role of c-Jun N-terminal kinase in cerebral vasospasm after experimental subarachnoid hemorrhage. Stroke 2005, 36:1538-1543. 10.1161/01.STR.0000170713.22011.c8, 15947258.
102. Zhou C, Yamaguchi M, Colohan AR, Zhang JH. Role of p53 and apoptosis in cerebral vasospasm after experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab 2005, 25:572-582. 10.1038/sj.jcbfm.9600069, 15729295.
103. Yarnitsky D, Lorian A, Shalev A, Zhang ZD, Takahashi M, Agbaje-Williams M, Macdonald RL. Reversal of cerebral vasospasm by sphenopalatine ganglion stimulation in a dog model of subarachnoid hemorrhage. Surg Neurol 2005, 64:5-11. 10.1016/j.surneu.2004.09.029, 15993169.
104. Sabri M, Kawashima A, Ai J, Macdonald RL. Neuronal and astrocytic apoptosis after subarachnoid hemorrhage: a possible cause for poor prognosis. Brain Res 2008, 1238:163-171. 10.1016/j.brainres.2008.08.031, 18786513.
105. Head E, Pop V, Vasilevko V, Hill M, Saing T, Sarsoza F, Nistor M, Christie LA, Milton S, Glabe C. A two-year study with fibrillar beta-amyloid (Abeta) immunization in aged canines: effects on cognitive function and brain Abeta. J Neurosci 2008, 28:3555-3566. 10.1523/JNEUROSCI.0208-08.2008, 18385314.
106. Milgram NW, Adams B, Callahan H, Head E, Mackay B, Thirlwell C, Cotman CW. Landmark discrimination learning in the dog. Learn Mem 1999, 6:54-61. 311280, 10355524.
107. Milgram NW, Zicker SC, Head E, Muggenburg BA, Murphey H, Ikeda-Douglas CJ, Cotman CW. Dietary enrichment counteracts age-associated cognitive dysfunction in canines. Neurobiol Aging 2002, 23:737-745. 10.1016/S0197-4580(02)00020-9, 12392778.
108. Milgram NW, Head E, Zicker SC, Ikeda-Douglas C, Murphey H, Muggenberg BA, Siwak CT, Tapp PD, Lowry SR, Cotman CW. Long-term treatment with antioxidants and a program of behavioral enrichment reduces age-dependent impairment in discrimination and reversal learning in beagle dogs. Exp Gerontol 2004, 39:753-765. 10.1016/j.exger.2004.01.007, 15130670.
109. Robbins TW. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 2002, 163:362-380. 10.1007/s00213-002-1154-7, 12373437.
110. Mavaddat N, Sahakian BJ, Hutchinson PJ, Kirkpatrick PJ. Cognition following subarachnoid hemorrhage from anterior communicating artery aneurysm: relation to timing of surgery [see comments]. J Neurosurg 1999, 91:402-407. 10.3171/jns.1999.91.3.0402, 10470814.
111. Rodholm M, Hellstrom P, Bilting M, Starmark JE. Diagnostic classification of organic psychiatric disorders after aneurysmal subarachnoid hemorrhage: a comparison between ICD-10, DSM-IV and the Lindqvist & Malmgren classification system. Acta Psychiatr Scand 2003, 108:222-231. 10.1034/j.1600-0447.2003.00094.x, 12890278.
112. Towgood K, Ogden JA, Mee E. Neurological, neuropsychological, and functional outcome following treatment for unruptured intracranial aneurysms. J Int Neuropsychol Soc 2005, 11:522-534. 10.1017/S1355617705050630, 16212679.